HKU Scholars Hub: Browsing DSpace

Browsing by Author Hsu, CW

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 8 of 8

	Title	Author(s)	Issue Date
	Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir Journal:Hepatology	Leung, N Peng, CY Hann, HW Sollano, J LaoTan, J Hsu, CW Lesmana, L Yuen, MF Jeffers, L Sherman, M Min, A Mencarini, K Diva, U Cross, A Wilber, R LopezTalavera, J	2009
	Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment Proceeding/Conference:Journal of Hepatology	Lai, CL Elion, R Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mercarni, K Zhang, H Iloeje, UH Kreter, B	2009
	Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment Proceeding/Conference:Gastroenterology	Lai, CL Elion, RA Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mencarini, KA Zhang, H Iloeje, UH Kreter, B	2009
	Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A Journal:Journal of Clinical Oncology	Furman, WL McCarville, B Shulkin, BL Davidoff, A Krasin, M Hsu, CW Pan, H Wu, J Brennan, R Bishop, MW Helmig, S Stewart, E Navid, F Triplett, B Santana, V Santiago, T Hank, JA Gillies, SD Yu, A Sondel, PM Leung, WH Pappo, A Federico, SM	2022
	Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Hsu, CW Chen, YC Liaw, YF Gane, E Manns, M Zeuzem, S Wang, Y Lai, CL Hou, J Leung, N Bzowej, N Niu, J Jia, J Hwang, SG Cakaloglu, Y Ren, H Papatheodoridis, G Chen, Y Bao, W Lopez, P	2009
	Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine	Lai, CL Gane, E Liaw, YF Hsu, CW Thongsawat, S Wang, Y Chen, Y Heathcote, EJ Rasenack, J Bzowej, N Naoumov, NV Di Bisceglie, AM Zeuzem, S Moon, YM Goodman, Z Chao, G Constance, BF Brown, NA	2007
	Telbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response Proceeding/Conference:Hepatology International	Lai, CL Gane, E Hsu, CW Chen, YC Thongsawat, S Wang, Y Chen, Y Naoumov, N Han, SH Hwang, SG Lim, SG Brown, NA	2007
	Two-year Results from the Globe Trial in Patients with Hepatitis B: Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine Proceeding/Conference:Hepatology	Lai, CL Gane, E Hsu, CW Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Rasenack, J Bzowej, N Naoumov, N Zeuzem, S Di Bisceglie, A Chao, GC Barbara, A Constance, F Brown, NA Study Group The GLOBE.,	2006

Showing results 1 to 8 of 8